She might not have been able to do that for her grandmother. But she can for other families. In honor of her grandmother, ...

For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.

As National Alzheimer's Awareness Month spotlights new treatments, healthcare ETFs like XLV and VHT might gain fresh investor ...

Eli Lilly and rival drugmaker Novo Nordisk are the leading companies in the GLP-1 space, but others are emerging. Among them ...

President Donald Trump announced deals with Eli Lilly and Novo Nordisk to slash the prices of some of their obesity drugs, ...

Investing in pharmaceutical companies with diversified revenue bases and strong R&D pipelines could be a lucrative strategy.

Eli Lilly and Novo Nordisk officials have agreed to lower the cost of GLP-1 obesity drugs for Medicaid and Medicare ...

Thirty-year life science industry specialist Dr Mike Hutton has been appointed to the Scientific Advisory Board of Cambridge ...

The deal will help expand the availability and marketing of this weight-loss medicine, especially in areas where Novo Nordisk ...

Innovative biopharmaceutical company Metsera (NASDAQ: MTSR) has been climbing all year. It went public on Feb. 3 of this year ...

To build the industry's most powerful AI supercomputer, supercharging medicine discovery and delivery for patients ...